Episode #70
COVID-19 Series Ep. 2: Accountability, Public Trust & the Questions We Must Still Ask
The COVID-19 pandemic changed healthcare, public policy, science, and the lives of billions of people around the world. As the immediate emergency has passed, many important questions remain. In this episode of Humanitarian Horizons, pharmaceutical executive, regulatory strategist, entrepreneur, and patient advocate Christina DiArcangelo examines the ongoing conversation surrounding the COVID-19 response, congressional oversight, public trust, scientific transparency, and the lessons that healthcare leaders must carry forward. Topics discussed include: ✔ Congressional investigations into the federal COVID-19 response ✔ Dr. Anthony Fauci's public testimony and the importance of oversight ✔ Public debate surrounding COVID-19 policies during the Biden administration ✔ Operation Warp Speed and accelerated vaccine development ✔ Vaccine mandates and the ethical considerations surrounding public health policy ✔ Pharmacovigilance and post-market safety monitoring ✔ Adverse-event reporting and scientific transparency ✔ Accountability in government, healthcare, and the pharmaceutical industry ✔ Restoring public trust through openness, humility, and patient-centered leadership As someone with decades of experience in pharmaceutical development, biotechnology, FDA regulatory strategy, and patient advocacy, Christina shares her perspective on why accountability, scientific integrity, and transparency remain essential to protecting patients and strengthening public confidence in healthcare. This episode is intended to encourage thoughtful discussion about healthcare ethics, leadership, regulatory oversight, and the future of public health. Subscribe to Humanitarian Horizons for conversations that explore healthcare, patient advocacy, leadership, humanitarian issues, and the future of medicine. COVID-19, COVID, COVID pandemic, COVID accountability, COVID congressional investigations, COVID oversight, Anthony Fauci, Congress, public trust, public health, healthcare leadership, patient advocacy, FDA, NIH, CDC, Operation Warp Speed, vaccine policy, vaccine mandates, pharmacovigilance, drug safety, adverse event reporting, clinical research, drug development, pharmaceutical industry, biotechnology, scientific transparency, medical ethics, healthcare ethics, Christina DiArcangelo, Humanitarian Horizons, government accountability, health policy, regulatory affairs, clinical trials, healthcare reform, united states #COVID19, #PublicHealth, #Healthcare, #PatientAdvocacy, #ScientificIntegrity, #Leadership, #ClinicalResearch, #FDA, #HealthcareLeadership, #MedicalEthics, #GovernmentAccountability, #HumanitarianHorizons, #ChristinaDiArcangelo #unitedstates
